about
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal FluidSTROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease.Diagnostic Accuracy of T1-Weighted Dynamic Contrast-Enhanced-MRI and DWI-ADC for Differentiation of Glioblastoma and Primary CNS Lymphoma.Cost Related to Dementia in the Young and the Impact of Etiological Subtype on Cost.Development and validation of a risk score (CHANGE) for cognitive impairment after ischemic stroke.Cognitive Impairment after Mild Stroke: Development and Validation of the SIGNAL2 Risk Score.Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.Treatment of Brain Metastases.Intravascular large B-cell lymphoma presenting as panniculitis clinically: a case report.Clinicoradiologic features distinguish tumefactive multiple sclerosis from CNS neoplasms.High-dose cefazolin on consecutive hemodialysis in anuric patients with Staphylococcal bacteremiaNumb cheek syndrome: a clinical-anatomical correlation. Diagnosis: Trigeminal schwannomaAtypical radiological findings of primary central nervous system lymphomaPretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphomaBevacizumab in high-grade glioma patients following intraparenchymal hemorrhageTargeted Therapies for the Treatment of Glioblastoma in Adults
P50
Q37168845-B757781E-966D-41D8-BCA8-3DCBF289D34BQ37600673-0A1A3233-FCEB-4C2D-8866-295C53F36C7AQ40433973-937972A0-E526-4274-88AA-E6DA611EB705Q40457882-851842C6-1864-46A5-A0FE-4EFE0ED42D13Q42367770-4B238470-5967-4A17-B978-E3659D9A7128Q52146533-C72D1E5D-D1F9-4E08-8528-4C71DCA5C541Q52570231-1BC1727A-0F93-4C94-9665-DB3C047111A1Q53827061-25D9BD7B-464C-4EEC-8E36-EC313D7440F0Q54962790-D0675BE8-BB35-4003-B2BD-402C7AC9754DQ55260453-87FC08BA-79BB-42E0-A1CC-E19E9A970757Q82597038-38509C04-FC1D-4BBF-BCED-A5509918192BQ86547997-92C5D269-57A4-4E69-98B2-D308F4EC7384Q89799722-84A94086-72B2-4680-AA12-792711816FE5Q90730534-033A6660-379E-441A-88AB-03E376BFFDF6Q91679645-3F20F262-71B0-4AD1-8F7B-8225BED0131AQ92127069-F56B3B2E-F1DC-4CC3-8312-6D81E02B58EC
P50
description
researcher ORCID ID = 0000-0001-9551-7659
@en
wetenschapper
@nl
name
Xuling Lin
@ast
Xuling Lin
@en
Xuling Lin
@es
Xuling Lin
@nl
type
label
Xuling Lin
@ast
Xuling Lin
@en
Xuling Lin
@es
Xuling Lin
@nl
prefLabel
Xuling Lin
@ast
Xuling Lin
@en
Xuling Lin
@es
Xuling Lin
@nl
P106
P31
P496
0000-0001-9551-7659